Stock Performance and Market Context
On 10 June 2026, Aster DM Healthcare Ltd’s share price surged to an intraday high of Rs.806.9, representing a 2.11% increase on the day and a 1.74% gain compared to the Sensex’s 0.54% rise. This marks the highest price level ever recorded for the stock, surpassing previous resistance levels and setting a new benchmark for investors.
The stock has demonstrated consistent strength, outperforming its hospital sector peers by 0.89% on the day. Over the past week, the share price has gained 10.82%, reflecting a sustained bullish momentum. This seven-day rally is part of a broader upward trend, with the stock outperforming the Sensex significantly across multiple time frames.
Comparative Returns Over Various Periods
Aster DM Healthcare Ltd’s performance over the last year has been particularly notable, delivering a 41.30% return compared to the Sensex’s decline of 9.80%. Year-to-date, the stock has risen 30.47%, while the Sensex has fallen by 12.79%. Over three years, the company’s shares have appreciated by an impressive 184.90%, far outpacing the Sensex’s 18.67% gain. The five-year return stands at a remarkable 413.57%, dwarfing the Sensex’s 42.10% increase over the same period.
These figures highlight the stock’s resilience and ability to generate substantial shareholder value relative to the broader market and sector benchmarks.
Technical Indicators and Trend Analysis
The technical outlook for Aster DM Healthcare Ltd remains strongly bullish. The stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained upward momentum. Key technical indicators such as MACD, Bollinger Bands, and Dow Theory are aligned with a bullish trend on both weekly and monthly timeframes.
Immediate support is established at the 52-week low of Rs.519.80, while the stock has recently surpassed resistance levels around Rs.747.38 (20-day moving average) and Rs.662.31 (100-day moving average). The new all-time high at Rs.806.90 now represents a far resistance level, setting a fresh target for technical analysts.
Delivery volumes have also shown a positive trend, with a 25.56% increase over the past month and a significant 152.46% rise in delivery volume on the day compared to the five-day average. This indicates strong participation from shareholders and institutional investors alike.
Valuation Metrics and Dividend Profile
At the current price of approximately Rs.804, Aster DM Healthcare Ltd trades at a price-to-earnings (P/E) ratio of 101 times trailing twelve months earnings, reflecting a premium valuation consistent with its growth profile. The price-to-book value stands at 8.95 times, while enterprise value multiples such as EV/EBITDA and EV/EBIT are 46.45x and 65.72x respectively, indicating elevated market expectations.
The company maintains a dividend yield of 0.51%, with the latest dividend declared at Rs.3 per share and a payout ratio of 77.28%. The ex-dividend date was 2 April 2026, underscoring Aster DM Healthcare’s commitment to returning value to shareholders alongside capital appreciation.
Quality and Financial Trends
Aster DM Healthcare Ltd is classified as an average quality company based on long-term financial performance. Management risk is rated as good, while growth metrics are below average. The company’s capital structure is considered average, with moderate debt levels and low leverage (net debt to equity ratio of 0.20).
Institutional holdings are robust at 44.76%, reflecting healthy participation from large investors. The company has demonstrated consistent dividend payments and maintains an average return on equity (ROE) of 18.40%, which is considered good, although return on capital employed (ROCE) is weaker at 10.38%.
Financial trends for the short term are flat as of March 2026, but quarterly results show positive momentum with profit before tax (excluding other income) growing by 48.02% to ₹126.82 crores and the highest quarterly PAT recorded at ₹139.86 crores. Earnings per share (EPS) for the quarter reached a peak of ₹2.71.
Historical Price Range and Market Capitalisation
The stock’s 52-week price range spans from a low of Rs.519.80 to the new high of Rs.806.90, with the current price just 0.36% below the all-time peak. This wide range illustrates the stock’s significant appreciation over the past year. Aster DM Healthcare Ltd is categorised as a small-cap company, reflecting its market capitalisation relative to larger peers in the hospital sector.
Since the trend change on 23 April 2026 at Rs.687.8, the stock has maintained a bullish trajectory, confirming the strength of its recent gains.
Summary of Key Metrics
• New all-time high price: Rs.806.9 (10 June 2026)
• Day’s gain: 1.74%
• 7-day return: 10.82%
• 1-year return: 41.30%
• 5-year return: 413.57%
• P/E ratio (TTM): 101x
• Dividend yield: 0.51%
• Institutional holdings: 44.76%
• Delivery volume increase (1 month): 25.56%
The achievement of a new all-time high by Aster DM Healthcare Ltd is a testament to its sustained market performance and underlying financial strength. The stock’s consistent outperformance relative to the Sensex and its sector peers, combined with positive technical indicators and solid institutional support, mark this milestone as a significant event in the company’s market journey.
